Author

Hagai Ligumsky

Observed names: H Ligumsky, H. Ligumsky, Hagai Ligumski, Ligumsky, Hagai

Institutions: Tel Aviv University, Tel Aviv Sourasky Medical Center

Observed institutions: Cedars-Sinai Medical Center, University of California, Los Angeles, Tel Aviv University, Tel Aviv Sourasky Medical Center, Sheba Medical Center, Ellison Medical Institute

ORCID: 0000-0002-5652-3703

Observed ORCID: 0000-0002-5652-3703

OpenAlex ID: A5035921078

Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility

2013 · Lital Kalich-Philosoph, Hadassa Roness, et al. · Science Translational Medicine · 543

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer

2008 · I Wolf, S Levanon-Cohen, et al. · Oncogene · 308

Butyrylcholinesterase attenuates amyloid fibril formation in vitro

2006 · Sophia Diamant, Erez Podoly, et al. · Proceedings of the National Academy of Sciences · 175

KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer

2011 · Lilach Abramovitz, Tamar Rubinek, et al. · Clinical Cancer Research · 134

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells

2011 · Hagai Ligumsky, Ido Wolf, et al. · Breast Cancer Research and Treatment · 114

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients

2021 · Hagai Ligumsky, Esraa Safadi, et al. · JNCI Journal of the National Cancer Institute · 80

PDF

The role of α-klotho in human cancer: molecular and clinical aspects

2022 · Hagai Ligumsky, Keren Merenbakh-Lamin, et al. · Oncogene · 50

Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis

2015 · Hagai Ligumsky, Tami Rubinek, et al. · Molecular Cancer Research · 49

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

2021 · Hagai Ligumsky, Herut Dor, et al. · The Lancet Oncology · 37

Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells

2024 · Hagai Ligumsky, Sharon Amir, et al. · Medical Oncology · 11

Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho

2023 · Marana Abboud, Keren Merenbakh-Lamin, et al. · Oncogene · 7

Genomic analysis of urothelial cancer and associations with treatment choice and outcome

2019 · D.L. Sarid, R. Berger, et al. · Annals of Oncology · 2

Session 30: Fertility preservation for medical and non-medical indications

2013 · H. Roness, L. Kalich-Philosoph, et al. · Human Reproduction · 2

Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells.

2010 · I. Wolf, H. Ligumsky, et al. · Journal of Clinical Oncology · 2

Expression and functional diversity of the glucagon-like peptide-1 receptor across tumor types

2025 · Mario M. Alba, Wilson H. Lee, et al. · Discover Oncology · 1

Monitoring the rate and variability of somatic genomic alterations using long-read sequencing

2025 · Xingyao Chen, Hagai Ligumsky, et al. · Scientific Reports · 1

PDF

Biom-22. Relevance of Tumor Mutation Burden (tmb) in High-grade Gliomas

2021 · Hagai Ligumsky, Deborah Blumenthal, et al. · Neuro-Oncology · 1

PDF

Abstract 1197: Perineural invasion on prostate biopsy is associated with higher decipher genomic risk and adverse molecular features in localized prostate cancer.

2026 · Hagai Ligumsky, Tamar Zahavi, et al. · Cancer Research

Correction to: Glucagon‑like peptide‑1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells

2026 · Hagai Ligumsky, Sharon Amir, et al. · Medical Oncology

PDF

[novel Technologies and Future Trends in Translational Research in Oncology].

2024 · Hagai Ligumsky, Yael Bar, et al. · PubMed

Supplementary Method and Figure Legend from Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis